Abstract: The present invention relates to new and useful processes for the preparation of the anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride.
Type:
Grant
Filed:
August 30, 2004
Date of Patent:
August 8, 2006
Assignee:
Apotex Pharmachem Inc.
Inventors:
Carlos Zetina-Rocha, Allan W. Rey, Stephen E. Horne
© 2026 Justia
